IPHA News
August 21, 2025
Thursday 21st August 2025 IPHA notes the joint statement by the US and EU on tariffs today (Thursday), particularly the aspects dealing with pharmaceuticals. Some mitigation […]
July 23, 2025
IPHA launches report that highlights the Socio-Economic Value of Self-Care.
June 30, 2025
A record level of 98% of Healthcare Professionals have provided named transparency on www.transfersofvalue.ie IPHA member company investment in R&D increases significantly Since July 2016, and […]
June 20, 2025
IPHA response to Sinn Féin’s Healthcare (Transparent Payments) Bill 2022 as disclosure rates continue to rise. Disclosure rates to named healthcare professionals for 2023 was 96%; 2024 […]
June 16, 2025
Dublin, 16 June 2025 – The Irish Pharmaceutical Healthcare Association (IPHA) and cormeo, the newly established German based Pharma Tech holding company under Bertelsmann, announces its […]
May 20, 2025
20 May 2025 The Irish Pharmaceutical Healthcare Association (IPHA) welcomes encouraging progress in clinical trials activity in Ireland over the past year, as reported in its […]
May 7, 2025
Ireland continues to rank among the bottom of Western European countries when it comes to availability of newly licensed cancer treatments, according to a new report by data analysts IQVIA for EFPIA, the European pharmaceutical body.
April 23, 2025
The objective of Directive 91/271/EEC is to protect the environment from being adversely affected byinsufficiently treated urban wastewater discharges.
February 26, 2025
Today, (Wednesday 26th February) the Irish Pharmaceutical Healthcare Association (IPHA) publishes a position paper on the 2025 Programme for Government Commitments which makes the case for Faster and Fairer Access to Medicines.